With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Characterization of Chromatin Landscapes to Identify Therapeutic Vulnerabilities in Diffuse Midline Gliomas.||Fred Hutchinson Cancer Research Center / Jay Sarthy, MD/PhD||Young Investigator Grants||2019||Washington|
|MLL Oncogene-Dependent Enhancer Reprogramming Promotes Leukemogenesis||Stanford University / Feng Pan, PhD||Young Investigator Grants||2019||California|
|Defining the Molecular Mechanisms Underlying Pediatric Brain Tumor Penetrance||Washington University / Nicole Brossier, MD/PhD||Young Investigator Grants||2019||Missouri|
|ECM-targeted CAR T-cell therapy for high-grade glioma||St. Jude Children's Research Hospital / Jessica Wagner, PhD||Young Investigator Grants||2019||Tennessee|
|Improving CAR T-Cell Therapy for Pediatric Osteosarcoma by Manipulating Arginine Metabolism||St. Jude Children's Research Hospital / Shannon Lange, PhD||Young Investigator Grants||2019||Tennessee|
|Targeting Valine-Specific Amino Acid Dependency -in T-Cell Acute Lymphoblastic Leukemia||New York University School of Medicine / Palaniraja Thandapani, PhD||Young Investigator Grants||2019||New York|
|Modeling H3 G34R and BCOR-Altered Glioma Pathogenesis Using Neural Stem Cells||The Johns Hopkins University School of Medicine / Satoshi Nakata, MD/PhD||Young Investigator Grants||2019||Maryland|
|The Role of Tumor Heterogeneity in Relapse of Pediatric Acute Myeloid Leukemia||Children's Hospital & Research Center at Oakland / Cheryl Peretz, MD||Young Investigator Grants||2019||California|
|Bcl2-Family Inhibitors in Neuroblastoma: Mechanism of Action, Therapy Resistance, and Development of Biomarkers||Children's Hospital of Philadelphia / Claudia Zapata, MD||Young Investigator Grants||2019||Pennsylvania|
|Using Splice Switching Oligonucleotides (SSOs) to target MDM2 for rhabdomyosarcoma therapy||Research Institute at Nationwide Children's Hospital / Dawn Chandler, PhD||Innovation Grants||2019||Ohio|